First vaccinations in Phase I clinical trial of Lassa fever vaccine candidate - IAVI. IAVI announces first vaccinations in Liberia Phase I clinical trial of Las
Could overly optimistic messages be contributing to the drop in global HIV/AIDS spending? - IAVI. A global mission to end AIDS by 2030 has caused a groundswell
Igniting passion for the long haul - IAVI. It is where 19 percent of the globe’s HIV-infected individuals live and where 15 percent of the new HIV infections oc
Is there an HIV prevention crisis? - IAVI. After marshaling great effort and achieving remarkable results in diagnosing HIV infections and providing life-saving
Monoclonal antibodies and their potential role in combatting COVID-19 - IAVI. Numerous monoclonal antibodies are already in development for both treatment and p